New Study Recommends Stopping GLP-1 Agonists 14 Days Before Total Joint Arthroplasty to Reduce Anesthesia Risks SAN DIEGO (March 10, 2025)Glucagon-like peptide-1 receptor agonists (GLP-1 agonists), such as semaglutide (e.g., Ozempic), have helped improve the management of type 2 diabetes and obesity
Given the ongoing popularity and high demand for GLP-1 drugs in the U.S., we expect both sides to continue litigating over these issues
Semaglutide, liraglutide and dulaglutide are GLP-1RAs, whereas tirzepatide is a dual GIP/GLP-1RA
Despite this conceptual shift, peptide mediators of bonemusclefat crosstalk remain among the most underexplored endocrine systems, in part because their biology challenges traditional organ-based models of metabolism
2024, p
When it comes to any class of medication, its good to have choices